Serum-epidemiological Survey of SARS-CoV-2, City of Beira (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Beira (InCOVID 2020) - Resultados Preliminares -
Prevalence
Dataset Records for Prevalence
Displaying 101 - 150 of 5192
Serum-epidemiological Survey of SARS-CoV-2, City of Tete (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Tete (InCOVID 2020) - Resultados Preliminares -
Seroprevalence of SARS-CoV-2 Infection Among Occupational Groups from Bucaramanga Metropolitan Area, Colombia. Preprint
GHDx Entry last modified on: Oct 5, 2022
Andhra Pradesh Sero Survey Show Nearly 20% of State’s Population Exposed to Covid-19
Survey:
Cross-sectional - Epi surveillance - Urban only
20% of Andhra Exposed to Covid, Sero-survey Finds, Exposure Highest Where Case Tally Lowest
Survey:
Cross-sectional - Epi surveillance - Urban only
Serum-epidemiological Survey of SARS-CoV-2, City of Maputo (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Maputo (InCOVID 2020) - Resultados Preliminares -
Assam's Sero-survey found 23.7 per cent Seroprevalence in the State
Survey:
Epi surveillance
Press Briefing: Sero Survey Delhi
Survey:
Cross-sectional - Urban only
Over 56% of Delhi has Covid-19 Antibodies: Health Minister Satyendar Jain on 5th Serosurvey
Survey:
Urban only
Serum-epidemiological Survey of SARS-CoV-2, City of Quelimane (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Quelimane (InCOVID 2020) - Resultados Preliminares -
[Preliminary results of the National Health and Nutrition Survey COVID-19]
Communiqué 255: Resultados preliminares de la Encuesta Nacional de Salud y Nutrición COVID-19
Survey:
Cross-sectional - Epi surveillance - Household - Individual - Nationally representative
Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020
GHDx Entry last modified on: Jun 17, 2021
Mexico National Health and Nutrition Survey (ENSANUT) about COVID-19 2020
Encuesta Nacional de Salud y Nutrición 2020 sobre Covid-19, ENSANUT Continua COVID-19
Epi surveillance:
Household - Interview - Urban-rural representative
Sero-pravelence of SARS CoV-2 IgM and IgG Antibodies Amongst Blood Donors in Nigeria. Preprint
Scientific literature:
Epi surveillance
United States - Ohio Prevalence of Current and Past COVID-19 in Adults July 2020
Prevalence of Current and Past COVID-19 in Ohio Adults
Survey:
Epi surveillance - Individual
SARS-CoV-2 Seroprevalence in 12 Cities of India from July-December 2020. Preprint
GHDx Entry last modified on: Mar 14, 2022
Epidemiological and Serological Surveillance of COVID-19 in Pune City, Technical Report, August 16, 2020
Technical Report (dt August 16, 2020): Epidemiological and Serological Surveillance of COVID-19 in Pune City
Survey:
Epi surveillance
Assam’s First Sero-survey Gets Underway, Here’s Everything You Need To Know About It
GHDx Entry last modified on: Aug 1, 2022
Norway SARS-CoV-2 Seroprevalence Residual Sera Follow-up Survey July-September 2020
Seroprevalence of SARS-CoV-2 in the Norwegian population measured in residual sera collected in late summer 2020
Survey:
Epi surveillance - Individual
The Burden of COVID-19 Infection in a Rural Tamil Nadu Community. Preprint
GHDx Entry last modified on: Mar 14, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Pemba (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Pemba (InCOVID 2020) - Resultados Preliminares -
Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample survey
GHDx Entry last modified on: Feb 10, 2022
Anti-SARS-CoV-2 IgG seroprevalence study among blood donors in the Republic of Srpska: a 30-day survey
Studija seroprevalencije anti-SARS-CoV-2 IgG kod davalaca krvi u Republici Srpskoj: 30-dnevno ispitivanje
Presence of antibodies against SARS-CoV-2 in the district area Rinkeby-Kista, Stockholm, 22–24 June 2020
Förekomsten av antikroppar mot SARS-CoV-2 i stadsdelsområdet Rinkeby-Kista, Stockholm, 22–24 juni 2020
Survey:
Community - Cross-sectional - Exam - Urban only
Sero-prevalence of SARS-CoV-2 Antibody Among Adults in the General Population in Diredawa, Ethiopia. Preprint
GHDx Entry last modified on: Sep 13, 2022
SARS-CoV-2 seroprevalence and characteristics of post-infection immunity in a general population cohort study in Catalonia, Spain. Preprint
GHDx Entry last modified on: May 12, 2022
Covid antibodies found in 97% of Delhi residents
Survey:
Epi surveillance
Montenegro Institute of Public Health COVID-19 Dashboard June 2020
GHDx Entry last modified on: May 12, 2022
Dramatic Rise of Seroprevalence Rates of SARS-CoV-2 Antibodies among Healthy Blood Donors: The evolution of a Pandemic. Preprint
GHDx Entry last modified on: Oct 6, 2022
India - Kerala COVID 19 Sero Surveillance Report August - September 2021
COVID 19 Sero Surveillance Report
Survey:
Cross-sectional - Epi surveillance
Canada - Quebec COVID-19 First Wave Blood Donor Seroprevalence Study 2020
Étude De Séroprévalence Des Anti-Sras-Cov-2 Chez Les Donneurs De Sang D’héma-Québec, Vers La Fin De La Première Vague De Covid-19
Survey:
Epi surveillance
In May 2020, 4.5% of the population of metropolitan France had developed antibodies against SARS-CoV-2
Survey:
Longitudinal
Increase in SARS-CoV-2 seroprevalence in healthy blood donors after the second wave of COVID-19 pandemic in South-Eastern Italy: evidence for asymptomatic young individuals as potential virus spreaders. Preprint
GHDx Entry last modified on: Mar 14, 2022
COVID-19: around 35 000 people have been tested
GHDx Entry last modified on: Feb 10, 2022
Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in Sergipe, Brazil
GHDx Entry last modified on: Jun 17, 2021
The seroprevalence of SARS-CoV-2 IgG antibodies among asymptomatic blood donors in Saudi Arabia
GHDx Entry last modified on: Jun 17, 2021
Fernando de Noronha: how an island controlled the community transmission of COVID-19 in Brazil. Preprint
GHDx Entry last modified on: Mar 14, 2022
Prevalence of SARS-CoV-2 Antibodies from a one-year National Serosurveillance of Kenyan Blood Transfusion Donors. Preprint
GHDx Entry last modified on: Mar 14, 2022
Strategies for Infection Control and Prevalence of Anti-SARS-CoV-2 IgG Antibodies in 4,554 Employees of a University Hospital in Munich, Germany. Preprint
GHDx Entry last modified on: Mar 14, 2022
COVID-19 at a metropolitan region: public polices and social vulnerability within an iniquity context. Preprint
COVID-19 em uma Região Metropolitana: vulnerabilidade social e políticas públicas em contextos de desigualdades
Canada COVID-19 Seroprevalence Report - April 2020 to January 2021
COVID-19 Public Seroprevalence Report April 2020 to January 2021
Epi surveillance:
Nationally representative
Chile Epidemiological Report on COVID-19 Disease 2020-2022
Informe Epidemiológico Enfermedad por SARS-CoV-2 (COVID-19)
Contrasting SARS-CoV-2 epidemics in Singapore: Cohort studies in migrant workers and the general population. Preprint
GHDx Entry last modified on: Mar 14, 2022
Benin Health Statistical Yearbook 2020
Annuaire des Statistiques Sanitaires 2020
Report:
Epi surveillance - Subnationally representative - Urban-rural representative
Bosnia and Herzegovina Renal Registry Renal Replacement Therapy Data 2020 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Spain - Cantabria Renal Registry Renal Replacement Therapy Data 2020 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Albania Renal Registry Renal Replacement Therapy Data 2020 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Ukraine Renal Registry Renal Replacement Therapy Data 2020 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Subscribe